MENU
+Compare
TOI
Stock ticker: NASDAQ
AS OF
Aug 11, 01:50 PM (EDT)
Price
$4.32
Change
+$0.04 (+0.93%)
Capitalization
393.39M

TOI Oncology Institute (The) Forecast, Technical & Fundamental Analysis

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education... Show more

TOI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TOI with price predictions
Aug 08, 2025

Aroon Indicator for TOI shows an upward move is likely

TOI's Aroon Indicator triggered a bullish signal on August 08, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 198 similar instances where the Aroon Indicator showed a similar pattern. In of the 198 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TOI moved above its 50-day moving average on July 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TOI crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TOI advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TOI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TOI broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TOI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TOI's P/B Ratio (77.519) is very high in comparison to the industry average of (6.623). P/E Ratio (0.000) is within average values for comparable stocks, (118.608). TOI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.029). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.804) is also within normal values, averaging (1.994).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TOI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
TOI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TOI is expected to report earnings to fall 35.71% to -9 cents per share on August 13

Oncology Institute (The) TOI Stock Earnings Reports
Q2'25
Est.
$-0.09
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.11
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.10
The last earnings report on March 24 showed earnings per share of -14 cents, missing the estimate of -7 cents. With 527.15K shares outstanding, the current market capitalization sits at 393.39M.
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
18000 Studebaker Road
Phone
+1 562 735-3226
Employees
800
Web
https://www.theoncologyinstitute.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVSTX22.260.18
+0.82%
Allspring Disciplined US Core C
HQITX21.500.12
+0.56%
Hartford Equity Income R5
SBMBX11.720.01
+0.09%
Saratoga Energy & Basic Materials A
TVIFX82.52N/A
N/A
Thornburg Small/Mid Cap Core I
POIIX15.90-0.03
-0.19%
Polen International Growth Institutional

TOI and Stocks

Correlation & Price change

A.I.dvisor tells us that TOI and NUTX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TOI and NUTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOI
1D Price
Change %
TOI100%
+2.88%
NUTX - TOI
21%
Poorly correlated
-1.47%
CCEL - TOI
14%
Poorly correlated
+1.03%
ASTH - TOI
13%
Poorly correlated
+30.85%
CYH - TOI
12%
Poorly correlated
+1.22%
PIII - TOI
11%
Poorly correlated
-1.90%
More

Groups containing TOI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOI
1D Price
Change %
TOI100%
+2.88%
Hospital/Nursing Management
industry (90 stocks)
8%
Poorly correlated
+2.53%